Results 251 to 260 of about 10,847,213 (333)
Revised Control Barrier Function with Sensing of Threats from Relative Velocity Between Humans and Mobile Robots. [PDF]
Zeng Z+5 more
europepmc +1 more source
THE DEFENSE OF THE HUMAN BODY AGAINST LIVING MAMMALIAN CELLS
Harvey B. Stone
openalex +2 more sources
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source
One health surveillance: linking human and animal rabies surveillance data in Kenya. [PDF]
Kahariri S+6 more
europepmc +1 more source
A compendium of the anatomy of the human body intended principally for the use of students
Andrew Fyfe, Adam Black
openalex +2 more sources
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim+11 more
wiley +1 more source
The evolution of infant-directed communication: Comparing vocal input across all great apes. [PDF]
Wegdell F+13 more
europepmc +1 more source
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez+5 more
wiley +1 more source
Knowledge, attitudes, and practices regarding anthrax among affected communities, Kazo district, South-Western uganda, May 2022. [PDF]
Senyange S+4 more
europepmc +1 more source